Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis
- 19 November 2020
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 160 (2), 405-412
- https://doi.org/10.1016/j.ygyno.2020.11.012
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Role of bleeding recognition and evaluation in Black-White disparities in endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2018
- Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancerTumori Journal, 2018
- International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013JNCI Journal of the National Cancer Institute, 2017
- Race‐specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patientsCancer, 2017
- Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Stage IV Uterine Serous CarcinomaInternational Journal of Gynecologic Cancer, 2015
- Adjuvant chemotherapy for advanced endometrial cancerEmergencias, 2014
- Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United StatesGynecologic Oncology, 2013
- Using the NCDB for cancer care improvement: An introduction to available quality assessment toolsJournal of Surgical Oncology, 2009
- Stage IVB endometrial cancer: Does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysisGynecologic Oncology, 2009
- Stage IVB Endometrial Carcinoma: The Role of Cytoreductive Surgery and Determinants of SurvivalGynecologic Oncology, 2000